BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6410347)

  • 21. Bladder wall fibrosis following intravesical mitomycin treatment for superficial bladder cancer.
    Katz G; Hackett RL; Wajsman Z
    Urology; 1996 Jun; 47(6):928-9. PubMed ID: 8677595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei.
    Wheeless LL; Reeder JE; Han R; O'Connell MJ; Frank IN; Cockett AT; Hopman AH
    Cytometry; 1994 Dec; 17(4):319-26. PubMed ID: 7875039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonpapillary lesions of the urinary bladder: a retrospective study.
    Schujman E; Mukamel E; Slutzker D; Vilcovsky E; Servadio C
    Isr J Med Sci; 1983 Jul; 19(7):619-25. PubMed ID: 6885346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights from a whole cystectomy specimen--association of primary small cell carcinoma of the bladder with transitional cell carcinoma in situ.
    Gaisa NT; Tilki D; Losen I; Dahl E; Stoehr R; Stief CG; Knüchel R
    Hum Pathol; 2008 Aug; 39(8):1258-62. PubMed ID: 18547617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.
    Horikawa Y; Sugano K; Shigyo M; Yamamoto H; Nakazono M; Fujimoto H; Kanai Y; Hirohashi S; Kakizoe T; Habuchi T; Kato T
    J Urol; 2003 Apr; 169(4):1541-5. PubMed ID: 12629411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Low-grade and low-stage transitional carcinoma of the bladder. Review].
    Escudero Barrilero A; Gutiérrez Sanz Gadea C; Hernández Fernández C; Romero Maroto J; Tallada Buñuel M; Perales Cabanas L
    Actas Urol Esp; 1985; 9(3):203-8. PubMed ID: 3898736
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fluorescence in situ hybridization in diagnosis of urinary bladder cancer].
    Stroganova AM; Khachaturian AV
    Arkh Patol; 2006; 68(5):43-6. PubMed ID: 17144532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathological study of 110 cystectomy specimens for bladder cancer by an original mapping method.
    Hind A; Ventura L; Leocata P; Calvisi G; Partenzi A; Discepoli S; Ventura T; Carter SS
    J Exp Clin Cancer Res; 1998 Mar; 17(1):59-64. PubMed ID: 9646234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [So-called silent bladder cancer].
    Nagayama T; Kataumi S
    Nihon Hinyokika Gakkai Zasshi; 1972 Jun; 63(6):427-37. PubMed ID: 4672397
    [No Abstract]   [Full Text] [Related]  

  • 30. [A method of semiautomatic quantimetry in urinary cytology. Apropos of 28 cases].
    Visseaux-Coletto B; Adnet JJ
    Arch Anat Cytol Pathol; 1984; 32(6):339-48. PubMed ID: 6529266
    [No Abstract]   [Full Text] [Related]  

  • 31. [At-random biopsies in patients with cancer of the bladder].
    de Campos Freire G; Cordeiro P; Yamada RT; Monteiro Júnior J; Saldanha LB; Arap S
    Arch Esp Urol; 1988; 41(1):33-5. PubMed ID: 3369888
    [No Abstract]   [Full Text] [Related]  

  • 32. Approaches to the treatment of bladder cancer at Stanford.
    Torti FM
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S63-6. PubMed ID: 2444355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report.
    DeFuria MD; Bracken RB; Johnson DE; Soloway MS; Merrin CE; Morgan LR; Miller HC; Crooke ST
    Cancer Treat Rep; 1980; 64(2-3):225-30. PubMed ID: 7407754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formal discussion of "Clinical Observations on Sixty-nine Cases of in Situ Carcinoma of the Urinary Bladder".
    Koss LG
    Cancer Res; 1977 Aug; 37(8 Pt 2):2799. PubMed ID: 872106
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo muscle invasive bladder cancer: is there a change in trend?
    Vaidya A; Soloway MS; Hawke C; Tiguert R; Civantos F
    J Urol; 2001 Jan; 165(1):47-50; discussion 50. PubMed ID: 11125361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of intravesical instillation of antitumor agents on bladder cancer].
    Tomiyama T
    Nihon Hinyokika Gakkai Zasshi; 1972 Jul; 63(7):497-518. PubMed ID: 4628074
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathologist's role in bladder cancer.
    Farrow GM
    Semin Oncol; 1979 Jun; 6(2):198-206. PubMed ID: 482961
    [No Abstract]   [Full Text] [Related]  

  • 40. A murine model for bladder cancer.
    Murphy GP; Sandberg AA; Pontes JE; Ochi H; Yoshida M; Williams PD
    Prog Clin Biol Res; 1984; 162A():177-200. PubMed ID: 6541340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.